Premium
Just a couple of months after the Cabinet approved a bill to ban commercial surrogacy, two contrasting developments occurred in the in vitro fertilisation (IVF) market involving private equity players in the country. Firstly, a private equity firm made a fairly good investment in a home-grown IVF and secondly, a ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
